Blockchain Registration Transaction Record
GeoVax Labs, Inc. Reports Progress in COVID-19 Vaccine and Cancer Therapy Trials
GeoVax Labs, Inc. reports progress in multiple COVID-19 vaccine and cancer therapy trials, along with financial results for the third quarter of 2024. The company's ongoing efforts to develop innovative treatments and vaccines demonstrate its commitment to improving patient care worldwide.
This news matters because it highlights the ongoing efforts of GeoVax Labs, Inc. to develop innovative vaccines and therapies for COVID-19 and cancer. The progress in multiple trials and the financial results indicate the company's commitment to advancing life-changing treatments, which may have a significant impact on patient care worldwide.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x2f56103a7cdbfc10ada828aeba5f0af041c18cd50a4b2157b37f2862fb35732c |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | rift9nlK-d2160e2f5f1184379d61e522fb08ac96 |